A Nine-Strain Bacterial Consortium Improves Portal Hypertension and Insulin Signaling and Delays NAFLD Progression In Vivo.

The Inverse Simpson diversity index revealed that, although not reaching the microbial diversity levels of the control diet (CD) group, diversity improved over vehicle (HFGFD-VEH) in both treatment groups; this was nearly statistically significant in the bacterial consortium (HFGFD-CON) treatment group ( Figure 4 ).

also in 323 other papers

The Metabolic Profile Improved in the Treatment Groups Both microbiota-based treatments displayed an important reduction in fasting blood glucose and insulin levels, and HOMA-IR index with respect to the HFGFD-VEH group, although these differences did not reach statistical significance ( Table 1 and Figure S1B,C ).

also in 111,027 other papers